Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Thanks for posting House. Great find and well wort

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154912
(Total Views: 571)
Posted On: 03/09/2024 3:29:18 PM
Posted By: CGC
Re: HouseofCards #141726
Thanks for posting House. Great find and well worth the read. Particularly interesting to me as I have tried to work toward getting right to try (cancer) for an individual for several years. Without success. So in addition to Dr. J's spot on priorities- e,g., peer reviewed articles and partnerships- this is a also prime concern for many of us.

Highlights:

"I want to highly recommend that if you are waiting for a curative treatment (for me that’s drugs that impact the CCR5 receptor), you have the right to try investigational drugs that have not yet been approved.'

'I am getting an eIND for a drug I already trialed, so this will be considered expanded access for a previous patient. They can use my stats from the research, which already shows I responded extremely well to the drug, so there is less burden on proving the proposed treatment plan will be successful.

I am not sure if they are considering those who have not already trialed the drug or not. But it is called Leronlimab.'

' I know there’s a lot of opinion regarding Bruce Patterson, but I hosted some interviews with him on behalf of my nonprofit alongside some of the other long Covid nonprofits. He went into detail about treatment, ideas and protocols, including for MCAS mast cell activation, and for cytokine storm. He is the one who told me about this trial and recommended I try to get into it. Did NOT do any of his testing or treatments, but it did lead me in the way of proper clinical research.'



_____________
Posted By: HouseofCards

Looks like they're the same person that made the below reddit post yesterday. It was shared in one of the facebook groups this morning.

redditt- RTT- Covid Long Haulers


(3)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us